DrugPatentWatch Database Preview
BETA-VAL Drug Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
When do Beta-val patents expire, and what generic alternatives are available?
Beta-val is a drug marketed by Acp Nimble and is included in three NDAs.
The generic ingredient in BETA-VAL is betamethasone valerate. There are sixty-six drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the betamethasone valerate profile page.
US ANDA Litigation and Generic Entry Outlook for Beta-val
A generic version of BETA-VAL was launched as betamethasone valerate by FOUGERA PHARMS INC on December 11th, 2019.
Summary for BETA-VAL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 3 |
| Suppliers / Packagers: | 3 |
| Bulk Api Vendors: | 43 |
| Patent Applications: | 3,626 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | BETA-VAL at DailyMed |
Pharmacology for BETA-VAL
| Drug Class | Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Synonyms for BETA-VAL
| (11.beta.,16.beta.)-9.alpha.-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione 17.alpha.-valerate |
| (11beta,16beta)-9-fluoro-11,21-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl pentanoate |
| (2S,10S,11S,13S,15S,17S,1R,14R)-1-fluoro-17-hydroxy-14-(2-hydroxyacetyl)-2,13, 15-trimethyl-5-oxotetracyclo[8.7.0.0<2,7>.0<11,15>]heptadeca-3,6-dien-14-yl pe ntanoate |
| (8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl p |
| (8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl pentanoate |
| [(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] pentanoate |
| 1,4-Pregnadiene-11beta,17alpha,21-triol-9alpha-fluoro-16beta-methyl-3,20-dione 17-valerate |
| 12772-60-0 |
| 149665-14-5 |
| 152M445 |
| 2152-44-5 |
| 9-Fluoro-11-beta,17,21-trihydroxy-16-beta-methylpregna-1,4-diene-3,20-dione-17-valerate |
| 9-Fluoro-11.beta.,17,21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione 17-valerate |
| 9-Fluoro-11.beta.,21-dihydroxy-16.beta.-methyl-3,20-dioxopregna-1,4-dien-17-yl pentanoate # |
| 9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-valerate |
| 9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione-17-valerate |
| 9-fluoro-11beta,21-dihydroxy-16beta-methyl-3,20-dioxopregna-1,4-dien-17-yl pentanoate |
| 9-fluoro-11beta,21-dihydroxy-16beta-methyl-3,20-dioxopregna-1,4-dien-17-yl valerate |
| 944728-94-3 |
| 9alpha-Fluoro-16beta-methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione 17-valerate |
| 9alpha-Fluoro-16beta-methylprednisolone 17-valerate |
| 9IFA5XM7R2 |
| AB01274710_02 |
| AB01274710-01 |
| AB2000222 |
| AC1L285F |
| AKOS015994704 |
| AN-14218 |
| Bedermin |
| beta-Methasone 17-valerate |
| Beta-Val (TN) |
| Betaderm |
| Betamethason-17-valerate |
| Betamethasone 17-valerate |
| Betamethasone 17a-valerate |
| Betamethasone 17alpha-valerate |
| BETAMETHASONE VALERATE |
| Betamethasone Valerate (Betamethasone 17-Valerate) |
| Betamethasone valerate (Betnovate) |
| Betamethasone valerate (JP17/USP) |
| Betamethasone valerate [USAN:BAN:JAN] |
| Betamethasone valerate [USAN:USP:JAN] |
| Betamethasone-17-valerate |
| Betatrex (Salt/Mix) |
| Betaval |
| Betnesol V |
| Betnesol-V |
| Betneval |
| Betnovate |
| Betnovate;Celestone;Betaderm;Luxiq |
| Betnovateat |
| Betoid |
| Bettamousse |
| Bextasol |
| BRD-K34032314-001-04-1 |
| C27H37FO6 |
| CAS-2152-44-5 |
| Celestan V |
| Celestan-V |
| Celestane V |
| Celestoderm |
| Celestoderm V |
| Celestoderm-V |
| Celeston valerate |
| CHEBI:31277 |
| CHEMBL1497 |
| Chlorophytum Borivilanum |
| D01357 |
| Dermosol |
| Dermovaleas |
| DSSTox_CID_2673 |
| DSSTox_GSID_22673 |
| DSSTox_RID_76684 |
| DTXSID7022673 |
| Ecoval 70 |
| EINECS 218-439-3 |
| entanoate |
| Flubenisolonvalerate |
| Fuciderm |
| Gentocin (Salt/Mix) |
| Gentocin (Veterinary) |
| KS-1198 |
| LS-118456 |
| Luxiq |
| Luxiq (TN) |
| MFCD00867446 |
| MolPort-003-933-651 |
| NCGC00255185-01 |
| NCGC00274064-01 |
| Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16-methyl-17-((1-oxopentyl)oxy)-, (11beta,16beta)- |
| Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16-methyl-17-((1-oxopentyl)oxy)-,(11-beta,16-beta)- |
| Rinderon V |
| Rinderon-V (TN) |
| RL02645 |
| s1690 |
| SCHEMBL7270 |
| SNHRLVCMMWUAJD-SUYDQAKGSA-N |
| ST075178 |
| Stanoval |
| Tokuderm |
| Topagen (Salt/Mix) |
| Topagen (Veterinary) |
| Tox21_302288 |
| UNII-9IFA5XM7R2 |
| Valnac |
| ZINC3882052 |
US Patents and Regulatory Information for BETA-VAL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Acp Nimble | BETA-VAL | betamethasone valerate | CREAM;TOPICAL | 018642-001 | Mar 24, 1983 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Acp Nimble | BETA-VAL | betamethasone valerate | LOTION;TOPICAL | 070072-001 | Jun 27, 1985 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Acp Nimble | BETA-VAL | betamethasone valerate | OINTMENT;TOPICAL | 070069-001 | Dec 19, 1985 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
